Page last updated: 2024-11-03

praziquantel and Glomerulonephritis, Membranoproliferative

praziquantel has been researched along with Glomerulonephritis, Membranoproliferative in 1 studies

azinox: Russian drug

Glomerulonephritis, Membranoproliferative: Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dial, C1
Noël, LH1

Other Studies

1 other study available for praziquantel and Glomerulonephritis, Membranoproliferative

ArticleYear
Eggs in the kidney.
    Kidney international, 2010, Volume: 77, Issue:10

    Topics: Animals; Anthelmintics; Child; Glomerulonephritis, Membranoproliferative; Humans; Kidney; Male; Neph

2010